Press "esc" to clear
Go to Advanced Search

Showing results

110 of 2091
Embargo will expire:
27-Feb-2018 2:00 PM EST
Released to reporters:
23-Feb-2018 9:00 AM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 27-Feb-2018 2:00 PM EST

Channels:

Diabetes, OBGYN, Pharmaceuticals, Women's Health, Local - DC, Local - DC Metro, All Journal News

Article ID: 690035

American Society of Anesthesiologists and Premier Inc. Launch Next Generation of Perioperative Surgical Home Learning Collaborative

American Society of Anesthesiologists (ASA)

The American Society of Anesthesiologists (ASA) and Premier Inc. (NASDAQ: PINC), a leading health care improvement company, are accepting applications for the next phase of the jointly-led national Perioperative Surgical Home (PSH) Learning Collaborative.

Released:
23-Feb-2018 8:00 AM EST
EXPERT AVAILABLE
Add to Favorites

Channels:

Pharmaceuticals, Surgery, Local - Illinois, Local - Chicago Metro

Article ID: 689999

Fred Hutch, UW Medicine Alliance with Takeda to Advance Promising Early-Stage Research

Fred Hutchinson Cancer Research Center

Collaboration aims to accelerate next generation treatments in cancer, gastrointestinal diseases, and neurological disorders

Released:
22-Feb-2018 2:05 PM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

Cancer, Digestive Disorders, Pharmaceuticals

Article ID: 689969

Using Light and Gold for Targeted, Non-Invasive Drug Delivery

American Technion Society

Researchers have developed a highly-targeted and non-invasive drug-release method that combines a nanoscale gold particle-containing polymer coating and near-infrared light. The technology could also be used for other applications, including the sealing of internal and external injuries, and as biodegradable scaffolds for growing transplant organs.

Released:
22-Feb-2018 9:05 AM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

All Journal News, Cancer, Nanotechnology, Pharmaceuticals, Local - New York, Local - New York Metro

StergiosMoschosHorizontal2.jpg
  • Embargo expired:
    22-Feb-2018 9:00 AM EST

Article ID: 689651

Phase I Clinical Trial Shows Some Promise for Investigational Drug for Melanoma

University of North Carolina Health Care System

In JCI Insight, researchers reported the results of a phase I, multi-institution clinical trial for an investigational treatment for melanoma and other cancers with mutations in the BRAF or RAS genes.

Released:
19-Feb-2018 9:00 AM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

Cancer, Dermatology, Pharmaceuticals, All Journal News

Hawkins_Doug_042945_2016.PNG
  • Embargo expired:
    21-Feb-2018 5:00 PM EST

Article ID: 689653

Pediatric Oncology Expert Available to Discuss Larotrectinib Data Published in New England Journal of Medicine

Seattle Children's Hospital

Released:
16-Feb-2018 10:00 AM EST
EXPERT AVAILABLE
Add to Favorites
Comment
Hong_David.jpg
  • Embargo expired:
    21-Feb-2018 5:00 PM EST

Article ID: 689856

Kinase Inhibitor Larotrectinib Shows Durable Anti-Tumor Abilities in Patients of All Ages with 17 Unique Cancer Diagnoses

University of Texas M. D. Anderson Cancer Center

Three simultaneous safety and efficacy studies of the drug larotrectinib reported an overall response rate of 75 percent for patients ages four months to 76 years with 17 different cancer diagnoses.

Released:
20-Feb-2018 5:05 PM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

Cancer, Cell Biology, Pharmaceuticals, Local - Texas, Local - Houston Metro

Article ID: 689901

HIV Patch Being Developed to Reduce Transmission Rates in At-Risk Populations

Newswise

A novel microarray patch for HIV PrEP is in preparation for future clinical trials. The consortium of Queen’s University Belfast, along with their collaborators, PATH, ViiV Healthcare, the Population Council and LTS Lohmann Therapie-Systeme AG have been granted over $10 million by USAID for their research.

Released:
21-Feb-2018 11:05 AM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

AIDS and HIV, Biotech, Healthcare, Infectious Diseases, Pharmaceuticals, Public Health, Sex and Relationships, African News, Europe News, Local - Virginia

McElroyELF.JPG
  • Embargo expired:
    21-Feb-2018 8:00 AM EST

Article ID: 687494

Using Microscale Thermophoresis to Characterize Hits from High-Throughput Screening: A European Lead Factory Perspective

SLAS (Society for Laboratory Automation and Screening)

A perspective article in the March 2018 issue of SLAS Discovery from the biology group at the European Screening Centre Newhouse details how the European Lead Factory (ELF), a large publicly accessible drug discovery platform, uses microscale thermophoresis (MST) to aid in the prioritization of small molecule hits from high-throughput screening.

Released:
15-Feb-2018 5:05 AM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

All Journal News, Pharmaceuticals, Technology, Local - Illinois, Local - Chicago Metro

Article ID: 689879

Bench to Bedside

Harvard Medical School

To help catalyze the development of genetic therapies, Harvard Medical School is launching a new program aimed at educating pharma and biotech leaders on the latest advances in genetics and how to optimize them for drug discovery and other therapeutic innovations.

Released:
20-Feb-2018 5:05 PM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

Entrepreneurship, Genetics, Pharmaceuticals, Local - Massachusetts, Local - Boston Metro


Showing results

110 of 2091





Chat now!